0 200

Cited 0 times in

Comparison of Immunomodulative Effects of the Histamine-2 Receptor Antagonists Cimetidine, Ranitidine, and Famotidine on Peripheral Blood Mononuclear Cells in Gastric Cancer Patients

Authors
 K. B. Hahm  ;  W. H. Kim  ;  S. I. Lee  ;  J. K. Rang  ;  I. S. Park 
Citation
 SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, Vol.30(3) : 265-271, 1995-03 
Journal Title
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
ISSN
 0036-5521 
Issue Date
1995-03
MeSH
Adjuvants, Immunologic / pharmacology* ; Case-Control Studies ; Cimetidine / pharmacology* ; Cytotoxicity Tests, Immunologic ; Famotidine / pharmacology* ; Female ; Humans ; In Vitro Techniques ; Killer Cells, Natural / drug effects ; Killer Cells, Natural / immunology ; Leukocytes, Mononuclear / drug effects* ; Leukocytes, Mononuclear / immunology ; Lymphocyte Activation / drug effects ; Male ; Middle Aged ; Ranitidine / pharmacology* ; Receptors, Interleukin-2 / analysis ; Receptors, Interleukin-2 / drug effects ; Stomach Neoplasms / blood ; Stomach Neoplasms / immunology*
Abstract
Background: Histamine-2 receptor antagonists (H2-RA) have been shown to improve the function of various parts of the immune system. The proposed mechanism of the immunomodulative effects of H2-RA has been considered to be the inhibition of suppressor T-lymphocyte activity, an increase in interleukin-2 production, and an enhancement of natural killer cell activity. Most of these studies were done with cimetidine. Comparative data with other H2-RA are limited and conflict on immunomodulative effects. Comparison of the actions of H2-RA on the immune system is required. Methods: We compared the immunomodulative effect of the H2-RAs cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells (PBMC) in normal controls and patients with gastric cancer. DNA synthesis, cytotoxicity against K562 cells, and the levels of soluble interleukin-2 receptor (sIL-2R) in supernatant were measured after addition of the various H2-RA to PBMC cultures. Results: Subjects with gastric cancer showed significantly higher levels of suppressor lymphocyte activity than normal controls. These levels were restored to levels of normal controls by the addition of cimetidine. Statistically significant lymphoblastogenesis and cytotoxicity against K562 cells were observed only in cimetidine-treated PBMC (p < 0.05); such effects were not observed in ranitidine- or famotidine-treated PBMC. Significantly increased levels of sIL-2R were found in supernatants obtained from culture flasks treated with cimetidine and phytohemagglutinin or ranitidine and phytohemagglutinin (p < 0.01). Conclusions: Of the three H2-RAs tested, cimetidine had the strongest and famotidine the weakest immunomodulating effect. Only cimetidine augmented the cytotoxicity and proliferative response of lymphocyte to mitogen; neither ranitidine nor famotidine had such an effect. These results might be due to their structural differences. In addition, the immunologic effects of H2-RA are unlikely to be mediated via specific interaction at the H2 receptor.
Full Text
http://informahealthcare.com/doi/abs/10.3109/00365529509093275
DOI
10.3109/00365529509093275
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Lee, Sang In(이상인)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/186289
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links